May 25, 2026 03:33AM
May 15, 2026 02:55AM
May 8, 2026 02:48AM
May 8, 2026 02:48AM
May 8, 2026 02:47AM
Mar 31, 2026 03:12AM
Mar 23, 2026 03:50AM New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congress
Mar 17, 2026 07:39AM
Feb 6, 2026 06:17AM
Dec 8, 2025 06:42PM
Dec 8, 2025 04:52PM
Dec 8, 2025 04:40PM
Dec 4, 2025 02:13AM
Nov 18, 2025 07:02PM New data on lecanemab to be presented at CTAD conference
Nov 13, 2025 06:50PM
Nov 10, 2025 02:16AM
Oct 26, 2025 10:56PM
Sep 2, 2025 11:01PM
Aug 25, 2025 03:26AM
Jul 30, 2025 10:54PM
May 15, 2025 04:56AM Eisai projects Leqembi® revenue to total JPY 76.5 billion for fiscal year 2025 (April 2025 - March 2026)
May 8, 2025 07:49AM
Apr 1, 2025 06:14AM
Mar 25, 2025 03:08AM
Mar 17, 2025 01:49PM
Mar 3, 2025 03:17AM
Feb 28, 2025 08:11AM
Feb 18, 2025 02:13AM Leqembi® sales reaches €200 million - first sales milestone achieved
Jan 31, 2025 07:12AM
Jan 26, 2025 09:50PM
Jan 13, 2025 09:49PM
Dec 4, 2024 09:44PM
Nov 27, 2024 09:47PM
Nov 14, 2024 12:00PM
Oct 31, 2024 07:43PM Eisai completes rolling BLA submission for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US
Aug 13, 2024 10:42PM
Aug 1, 2024 07:09AM
Jul 30, 2024 05:19PM
Jul 26, 2024 07:49AM
Jul 26, 2024 06:59AM
Jul 23, 2024 02:42AM
Jul 11, 2024 10:59PM Leqembi approved for the treatment of Alzheimer's disease in Israel
Jul 10, 2024 10:51PM
Jun 27, 2024 10:48PM
Jun 9, 2024 10:55PM
May 14, 2024 10:52PM
Mar 31, 2024 11:19PM
Mar 11, 2024 03:18AM
Jan 11, 2024 01:16AM The European Medicines Agency's Scientific Advisory Group (SAG) to discuss the Marketing Authorisation Application for lecanemab: BioArctic
Jan 9, 2024 03:41AM

322,969 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All